Nurse Anesthetist - CR in Port Townsend, WA Accepting Medicare

8 Nurse Anesthetist - CR nurses found. Showing 1 - 8

Patricia L Stanwood, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 834 Sheridan St, Port Townsend, WA 98368 Phone: 360-385-2200    Fax: 360-379-2242

Maria Packard, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 834 Sheridan St, Port Townsend, WA 98368 Phone: 360-385-2200

Kory M Albert, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 834 Sheridan St, Port Townsend, WA 98368 Phone: 360-385-2200

Matthew D. Petta, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 628 Madison St, Port Townsend, WA 98368 Phone: 402-990-0733

Mr. Gustavo Pena, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 834 Sheridan St, Port Townsend, WA 98368 Phone: 360-385-2200

Brad T Walker, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 834 Sheridan St, Port Townsend, WA 98368 Phone: 360-385-2200

Colum Patrick Tinley, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 834 Sheridan St, Port Townsend, WA 98368 Phone: 360-385-2200

Mr. Todd A. Erickson, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 834 Sheridan St, Port Townsend, WA 98368 Phone: 360-385-2200    Fax: 360-379-2250

News Archive

Practical NCD guide for everyone to improve their health

The world's health professions have launched an easy-to-use, practical guide to help individuals and their health professionals reduce the risk of noncommunicable diseases (NCDs) - conditions which currently account for 60% of global deaths.

Researchers find new therapeutic target of biomedical interest in ischemic injury research

An international scientific team has developed a new small molecule -VH298- which can provoke a hypoxic response controlled from outside the cells, according to a study recently published in the magazine Nature Communications with its first authors being the expert Carles Galdeano, Beatriu de Pinós researcher at the Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry of the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine of the University of Barcelona, and Julianty Frost, from the University of Dundee.

Positive results from Amgen Sensipar/Mimpara Phase 3 trial for HPT, CKD

Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.

Qwest Communications to provide communications network solution to MPM-managed health care clinics

Memorial Practice Management (MPM) has selected Qwest Communications to provide an advanced communications network solution to connect seven MPM-managed health care clinics in central Washington.

Forest, Alkem and Torrent settle generic BYSTOLIC patent infringement litigation

Forest Laboratories, Inc. and Forest Laboratories Holdings, Ltd. announced today that they have entered into settlement agreements with Alkem Laboratories, Ltd., Indchemie Health Specialties Pvt. Ltd., and Torrent Pharmaceuticals Ltd. and Torrent Pharma Inc. in patent infringement litigation brought by Forest in response to abbreviated new drug applications (ANDAs) filed by Alkem, Indchemie and Torrent each seeking approval to market generic versions of Forest's BYSTOLIC (nebivolol) tablets.

Read more Medical News

› Verified 6 days ago